Regenerative medicine: Stroke survivor and carer views and motivations towards a proposed stem cell clinical trial using placebo neurosurgery.
Nicola A CunninghamPurva AbhyankarJulie CowieJayne GalinskyKaren MethvenPublished in: Health expectations : an international journal of public participation in health care and health policy (2017)
Stroke survivor views and motivations reflect anticipation of the personal and future benefits of regenerative medicine. Partners/carers sought to balance the value of stroke survivor hope with carrying the weight of hope as carer, a conflict burden adding to known caregiver burden. All participants expressed the need for during and post-trial psychological support. This study provides a rare opportunity to explore the prospective views and motivations of stroke survivors and their partners/carers towards a proposed Phase III 2-arm RCT. This adds weight to qualitative evidence exploring capacity, consent, decision making, perceptions of treatment risk and supports required for clinical trial participation.
Keyphrases
- phase iii
- clinical trial
- atrial fibrillation
- open label
- phase ii
- double blind
- stem cells
- physical activity
- study protocol
- decision making
- placebo controlled
- body mass index
- healthcare
- weight loss
- primary care
- randomized controlled trial
- weight gain
- young adults
- systematic review
- cell therapy
- hiv testing
- subarachnoid hemorrhage
- sleep quality
- replacement therapy
- hepatitis c virus
- antiretroviral therapy
- depressive symptoms